Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Rosetta Genomics (ROSG) - microRNA

No earlier versions found for this Subject.

Return to Rosetta Genomics (ROSG) - microRNA

Rosetta Genomics seeks to develop and commercialize diagnostic and therapeutic products based on a group of genes known as micro-ribonucleic acid (microRNAs).

MicroRNAs are naturally expressed, or produced, using instructions encoded in deoxyribonucleic acid (DNA). The Company has developed a discovery process that integrates computer-based algorithms and customized biological techniques in order to discover and biologically validate microRNAs.